Signature Diagnostics Appoints Rainer Kramer to Chief Business Officer and Member of the Management Board

05-Oct-2010 - Germany

Signature Diagnostics AG announced the appointment of Rainer Kramer as Chief Business Officer. Dr. Kramer previously held the position of Vice President Corporate Business Development at Jerini AG, where he was responsible for all licensing, partnering, and alliance management activities. Before joining Jerini, he performed various research and business development functions at MorphoSys AG, Martinsried, and Amgen Inc., Thousand Oaks.

Dr. Kramer holds a Diploma in Molecular Biology and a Ph.D from the Max-Planck-Institute for Neurobiology. Throughout his career in corporate business development, he contributed or delivered numerous strategic partnerships and license deals encompassing technology platform and product deals as well as equity transactions with an aggregate value of several hundred million Euros. As a member of Jerini's M&A committee, he was instrumental in the sale of Jerini to Shire in 2008 and was Shire's appointed principal for the sale of JPT GmbH in 2009.

Other news from the department people

Most read news

More news from our other portals